Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person AEE788 [cytosol]

Class:Id	ChemicalDrug:9652364
_displayName	AEE788 [cytosol]
_timestamp	2021-03-15 10:05:19
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9652361] Orlic-Milacic, Marija, 2019-06-28
crossReference	[DatabaseIdentifier:9717718] ChEBI:40629
disease	[Disease:1500689] cancer
modified	[InstanceEdit:9717734] Stephan, Ralf, 2021-03-15
name	AEE788
referenceEntity	[ReferenceTherapeutic:9652362] AEE788 [Guide to Pharmacology:7643]
stableIdentifier	[StableIdentifier:9652370] R-ALL-9652364.2
(hasMember)	[DefinedSet:9652360] lapatinib, neratinib, afatinib, AZ5104, tesevatinib, canertinib, sapitinib, CP-724714, AEE78 [cytosol] [DefinedSet:9655000] lapatinib,AEE788 [cytosol] [DefinedSet:9655204] AEE788,afatinib,lapatinib,neratinib,osimertinib [cytosol] [Homo sapiens] [DefinedSet:9655269] AEE788,sapitinib [cytosol] [CandidateSet:9655308] afatinib,CP-724714,canertinib,lapatinib,neratinib,osimertinib,(sapitinib) [cytosol] [DefinedSet:9665128] AEE788,CP-724714,Canertinib [cytosol]
(input)	[FailedReaction:9650278] ERBB2 V777L does not bind AEE788 [Homo sapiens] [FailedReaction:9665278] Resistant ERBB2 KD mutants do not bind AEE788 [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by AEE788 [cytosol] (9652364)